Jeffrey Kindler is the founder of Centrexion. Centrexion has raised $58M in total funding. Backed by Boehringer Ingelheim.
Jeffrey Kindler is the CEO of Centrexion, a biotech startup focused on creating a 'pain powerhouse' by developing early-stage programs with distinct mechanisms of action for pain management. He has led the company to raise $58 million in total funding so far and is currently in the process of raising a new funding round to support the company's expansion.
Full founder directory · Investor directory · Company funding database · Fundraising library